These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38585548)
1. Expanding the Phenotypic and Genotypic Spectrum of Weaver Syndrome: A Missense Variant of the Kendir-Demirkol Y; Yeter B; Jenny LA Mol Syndromol; 2024 Mar; 15(2):161-166. PubMed ID: 38585548 [TBL] [Abstract][Full Text] [Related]
2. The phenotype of EZH2 haploinsufficiency-1.2-Mb deletion at 7q36.1 in a child with tall stature and intellectual disability. Suri T; Dixit A Am J Med Genet A; 2017 Oct; 173(10):2731-2735. PubMed ID: 28696078 [TBL] [Abstract][Full Text] [Related]
3. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity. Lui JC; Barnes KM; Dong L; Yue S; Graber E; Rapaport R; Dauber A; Nilsson O; Baron J J Clin Endocrinol Metab; 2018 Apr; 103(4):1470-1478. PubMed ID: 29244146 [TBL] [Abstract][Full Text] [Related]
4. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype. Tatton-Brown K; Murray A; Hanks S; Douglas J; Armstrong R; Banka S; Bird LM; Clericuzio CL; Cormier-Daire V; Cushing T; Flinter F; Jacquemont ML; Joss S; Kinning E; Lynch SA; Magee A; McConnell V; Medeira A; Ozono K; Patton M; Rankin J; Shears D; Simon M; Splitt M; Strenger V; Stuurman K; Taylor C; Titheradge H; Van Maldergem L; Temple IK; Cole T; Seal S; ; Rahman N Am J Med Genet A; 2013 Dec; 161A(12):2972-80. PubMed ID: 24214728 [TBL] [Abstract][Full Text] [Related]
5. PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes. Cyrus S; Burkardt D; Weaver DD; Gibson WT Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):519-531. PubMed ID: 31724824 [TBL] [Abstract][Full Text] [Related]
7. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro. Cohen AS; Yap DB; Lewis ME; Chijiwa C; Ramos-Arroyo MA; Tkachenko N; Milano V; Fradin M; McKinnon ML; Townsend KN; Xu J; Van Allen MI; Ross CJ; Dobyns WB; Weaver DD; Gibson WT Hum Mutat; 2016 Mar; 37(3):301-7. PubMed ID: 26694085 [TBL] [Abstract][Full Text] [Related]
8. Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty. Okamoto N; Yoshida S; Ogitani A; Etani Y; Yanagi K; Kaname T Am J Med Genet A; 2024 Oct; 194(10):e63726. PubMed ID: 38814056 [TBL] [Abstract][Full Text] [Related]
9. Further Expansion of the Mutational Spectrum of 3MC Syndrome: A Novel Agaoglu NB; Akgun Dogan O Mol Syndromol; 2021 Oct; 12(6):379-385. PubMed ID: 34899147 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Tatton-Brown K; Hanks S; Ruark E; Zachariou A; Duarte Sdel V; Ramsay E; Snape K; Murray A; Perdeaux ER; Seal S; Loveday C; Banka S; Clericuzio C; Flinter F; Magee A; McConnell V; Patton M; Raith W; Rankin J; Splitt M; Strenger V; Taylor C; Wheeler P; Temple KI; Cole T; ; Douglas J; Rahman N Oncotarget; 2011 Dec; 2(12):1127-33. PubMed ID: 22190405 [TBL] [Abstract][Full Text] [Related]
11. EZH2 mutation in an adolescent with Weaver syndrome developing acute myeloid leukemia and secondary hemophagocytic lymphohistiocytosis. Usemann J; Ernst T; Schäfer V; Lehmberg K; Seeger K Am J Med Genet A; 2016 May; 170A(5):1274-7. PubMed ID: 26762561 [TBL] [Abstract][Full Text] [Related]
12. Novel EED mutation in patient with Weaver syndrome. Cooney E; Bi W; Schlesinger AE; Vinson S; Potocki L Am J Med Genet A; 2017 Feb; 173(2):541-545. PubMed ID: 27868325 [TBL] [Abstract][Full Text] [Related]
13. Novel mouse model of Weaver syndrome displays overgrowth and excess osteogenesis reversible with KDM6A/6B inhibition. Gao CW; Lin W; Riddle RC; Kushwaha P; Boukas L; Björnsson HT; Hansen KD; Fahrner JA bioRxiv; 2023 Jun; ():. PubMed ID: 37425751 [TBL] [Abstract][Full Text] [Related]
14. Novel variants in TNRC6B cause global developmental delay with speech and behavioral abnormalities, short stature, low body weight, café-au-lait spots, and metabolic abnormality. Yang Q; Ou S; Zhou X; Yi S; Lin L; Yi S; Zhang S; Qin Z; Luo J Mol Genet Genomic Med; 2024 Feb; 12(2):e2408. PubMed ID: 38404251 [TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic features of luscan-lumish syndrome associated with a novel de novo variant of Zhang Y; Zhang H; Wu W; Wang D; Lv Y; Zhao D; Wang L; Liu Y; Zhang K Front Genet; 2023; 14():1081391. PubMed ID: 36777730 [No Abstract] [Full Text] [Related]
17. Sotos syndrome with a novel mutation in the Verma A; Salehi P; Hing A; Curda Roberts AJ Int J Pediatr Adolesc Med; 2021 Sep; 8(3):191-194. PubMed ID: 34350334 [TBL] [Abstract][Full Text] [Related]
18. Mutations in SETD2 cause a novel overgrowth condition. Luscan A; Laurendeau I; Malan V; Francannet C; Odent S; Giuliano F; Lacombe D; Touraine R; Vidaud M; Pasmant E; Cormier-Daire V J Med Genet; 2014 Aug; 51(8):512-7. PubMed ID: 24852293 [TBL] [Abstract][Full Text] [Related]
19. Rare SUZ12 variants commonly cause an overgrowth phenotype. Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240 [TBL] [Abstract][Full Text] [Related]